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DOI 10.1186/s12889-015-1555-2RESEARCH ARTICLE Open AccessDifferent factors associated with loss to follow-up
of infants born to HIV-infected or uninfected
mothers: observations from the ANRS
12140-PEDIACAM study in Cameroon
Larissa Kamgue Sidze1,2, Albert Faye3,4, Suzie Ndiang Tetang5, Ida Penda6,7, Georgette Guemkam8,
Francis Ndongo Ateba8, Jean Audrey Ndongo8, Félicité Nguefack8,9, Gaëtan Texier1,10, Patrice Tchendjou1,2,
Anfumbom Kfutwah11, Josiane Warszawski12,13,14 and Mathurin Cyrille Tejiokem1,12*Abstract
Background: Loss to follow-up (LTFU) is a cause of potential bias in clinical studies. Differing LTFU between
study groups may affect internal validity and generalizability of the results. Understanding reasons for LTFU
could help improve follow-up in clinical studies and thereby contribute to goals for prevention, treatment, or
research being achieved. We explored factors associated with LTFU of mother-child pairs after inclusion in the
ANRS 12140-Pediacam study.
Methods: From November 2007 to October 2010, 4104 infants including 2053 born to HIV-infected mothers and
2051 born to HIV-uninfected mothers matched individually on gender and study site were enrolled during the first
week of life in three referral hospitals in Cameroon and scheduled for visits at 6, 10 and 14 weeks of age. Visits were
designated 1, 2 and 3, in chronological order, irrespective of the child’s age at the time of the visit. Mother-child
pairs were considered lost to follow-up if they never returned for a clinical visit within the first six months after
inclusion. Uni- and multivariable logistic regression were adjusted on matching variables to identify factors associated
with LTFU according to maternal HIV status.
Results: LTFU among HIV-unexposed infants was four times higher than among HIV-exposed infants (36.7% vs
9.8%, p < 0.001). Emergency caesarean section (adjusted Odds Ratio (aOR) = 2.46 95% Confidence Interval (CI)
[1.47-4.13]), young maternal age (aOR = 2.29, 95% CI [1.18-4.46]), and absence of antiretroviral treatment for
prophylaxis (aOR = 3.45, 95% CI [2.30-5.19]) were independently associated with LTFU among HIV-exposed infants.
Factors associated with LTFU among HIV-unexposed infants included young maternal age (aOR = 1.96, 95%
CI [1.36-2.81]), low maternal education level (aOR = 2.77, 95% CI [1.95-3.95]) and housewife/unemployed mothers
(aOR = 1.56, 95% CI [1.16-2.11]).
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Conclusion: Failure to return for at least one scheduled clinical visit is a problem especially among HIV-unexposed
infants included in studies involving HIV-exposed infants. Factors associated with this type of LTFU included
maternal characteristics, socio-economic status, quality of antenatal care and obstetrical context of delivery.
Enhanced counselling in antenatal and intrapartum services is required for mothers at high risk of failure to return for
follow-up visits.
Keywords: Loss to follow-up, Failed to return for scheduled clinical visits, Associated factors, Cohorts of HIV-exposed
and -unexposed infantsBackground
HIV/AIDS remains a disease of public health importance
and mother-to-child transmission (MTCT) is one of the
major problems [1]. Recent estimates of the Joint United
Nations Program on HIV/AIDS (UNAIDS) indicate that
approximately 330,000 children worldwide under 15 years
old became infected with HIV in 2012. Sub-Saharan Africa
is the most severely affected region, accounting for more
than 90 percent of paediatric HIV infections [1]. Most of
these infections occurred during pregnancy, delivery or
breastfeeding making the prevention of mother-to-child
transmission (PMTCT) a public health priority [2]. Over
the last few years, efforts have been made in Sub-Saharan
countries to improve PMTCT [3-5]. However, the effect-
iveness and efficacy of these interventions are profoundly
affected by high rates of loss to follow-up (LTFU) [6].
Studies in Malawi, Ivory coast and Angola have reported
cumulative losses in PMTCT programs of 20-28% during
antenatal care, to 70% four months post-partum and close
to 81% six months after birth [7-9]. LTFU has major impli-
cations for the understanding of the true mortality rates
among both HIV-positive and HIV-exposed children, as
well as for accurate determinations of HIV transmission
rates from mother to child [10].
Poor socioeconomic conditions have been identified as
the main reason for LTFU in such studies and PMTCT
programs. They include poverty, lack of paternal support,
poor mobility, long distances between residence and care
structures, and the cost of transport [11]. Therefore, it is
possible that in a context of favourable conditions (free
medical support, reminder phone calls, and incentives
including food vouchers or reimbursement of transport
fares) for follow-up, the problem of LTFU would be over-
come. LTFU is a problem not only for PMTCT programs
but also for clinical trials. LTFU in clinical trials can com-
promise study findings by reducing the power of a study
to detect a true difference between the control and the
intervention group. Differential LTFU may lead to bias
through exaggerated effects in one of the groups. These
issues can affect the results of a trial and in particular its
generalizability and internal validity [12]. Understanding
the reasons for LTFU among mother-infant pairs therefore
could improve follow-up in clinical studies; this in turnmay help achieve goals for prevention, treatment, or re-
search. The main objective of this study was to determine
factors associated with the failure of mother-child pairs to
return for scheduled clinical visit (even once) in the ANRS
12140-Pediacam study in Cameroon.
Methods
Data source
Data used in this analysis were obtained from the ANRS-
Pediacam cohort based in three referral hospitals in
Cameroon (The Maternity of the Central hospital/Mother
and Child Center of the Chantal Biya Foundation (MCH/
MCC-CBF), Essos Hospital Center in Yaoundé (EHC) and
the Laquintinie Hospital in Douala (LH)) and coordinated
by the Centre Pasteur of Cameroon. The ANRS 12140-
Pediacam study was designed to assess the feasibility of
early diagnosis of HIV and early antiretroviral multitherapy
in HIV-infected infants, and to evaluate the humoral re-
sponse of these children to vaccines of the Expanded Pro-
gram on Immunization (EPI).
The ANRS 12140-Pediacam is an ongoing prospective
cohort study involving two consecutive phases. The first
phase of the study included all infants born live to HIV-
infected mothers with documented serostatus (group 1)
identified before the 8th day of life from November 2007
to October 2010 and an equivalent number of infants born
to HIV-uninfected mothers matched individually on gen-
der and recruitment site. All newborns were expected to
attend a clinical visit, according to the Cameroon National
EPI calendar, at ages 6, 10 and 14 weeks for routine vac-
cination. Infant follow-up in the first phase was scheduled
to coincide with this EPI timetable to minimise the num-
ber of visits to the hospital required. However, visits (fol-
low-up visits) are designated hereafter as the first, second
and third, independent of the age of the child. Samples for
HIV virological testing were collected from HIV-exposed
infants at the first follow-up visit (scheduled for 6 weeks),
as previously described [13,14]. HIV test results were pro-
vided at the second visit (scheduled for 10 weeks). During
the second visit, all parents/caregivers who received a
negative result for their infants were counselled about
how to avoid practises favouring HIV transmission to their
infant. For breastfed infants whose first HIV test was
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weeks after weaning if asymptomatic. For infants with a
positive or indeterminate result from the first test, a blood
sample was collected at the second visit for confirmatory
testing. The results were announced at the third clinical
visit (scheduled for 14 weeks).
Incentives, including free medical support for consult-
ation, biological analysis, additional vaccines and reim-
bursement of transport costs, were provided to parents/
caregivers by the project during follow-up visits.
All HIV-infected children and control groups of HIV-
uninfected infants followed since birth, born to either
HIV-infected or non-infected mothers were eligible for
the second phase of the Pediacam project planned from
14 weeks to 5 years. This phase is not described here as
it is not relevant to this study.
Data collection
Socioeconomic and demographic characteristics of the
families and obstetrical characteristics were collected at
enrolment by questionnaire-based interview with mothers
and examination of their hospital booklets. Questionnaires
were also used subsequently to collect data on infant vital
status, pathologies, vaccinations and HIV testing process
as appropriate. Reminder phone calls were made to fam-
ilies who did not return for a follow-up visit within one
week of the planned date.
Ethical considerations
The ANRS 12140- Pediacam study has received ethical
approval in Cameroon from the National Ethic Com-
mittee and in France from the Biomedical Research
Committee of the Pasteur Institute of Paris. An administra-
tive authorization was also delivered by the Cameroonian
Ministry of Public Health. Written informed consent was
obtained from parents or guardians prior to inclusion of in-
fants into the research project.
Study population
All infants born live to HIV-infected mothers and in-
fants born to HIV-uninfected mothers matched on gen-
der and recruitment site, enrolled from November 2007
to October 2010 into the first phase of the ANRS-
Pediacam study planned from the first to 14th week of
life were eligible for this analysis.
Main outcome definition and covariables
The main outcome was loss to follow-up (LTFU) or
“failed to return for at least one scheduled clinical visit”
defined as mother-child pairs who never returned for a
clinical visit during the first 6 months of age after inclu-
sion in the ANRS-Pediacam study. Those who attended
clinical visits, even if only once, were not considered to
be lost to follow-up. The threshold of six months waschosen because several studies indicate that knowing the
HIV status of the child before age 6 months favours
early initiation of HAART [15,16]. Returning for a clin-
ical visit at least once within six months was perceived
as having the willingness to comply with the study
schedule; failure to attend subsequently may indicate
loss of motivation due to constraints associated with the
health system.
The covariables considered included variables pertaining
to infant’s characteristics at birth (gender, prematurity,
birth weight, APGAR, hospitalization at birth), maternal
characteristics and socio-economic status (HIV serological
status, marital status, level of education, socio-professional
activity, monthly income, presence of a functional fridge
at home, access to electricity, access to tap water), quality
of antenatal care and obstetrical context of delivery (primi-
gravid, mode of delivery, place of birth, number of ante-
natal visits, ART prophylaxis for PMTCT and disclosure
of HIV status) and paternal characteristics (age, level of
education and socio-professional activity).
Statistical analyses
Maternal and infant characteristics are described using fre-
quencies for categorical variables, medians and interquartile
ranges for continuous variables. Their relation to LTFU
was evaluated in each group defined by maternal HIV ser-
ostatus because of the differences observed between the
two groups. For multiple births, only the first infant was
included in the analysis. To examine covariables associated
with LTFU, logistic regression models were adjusted on site
and gender (matching variables) as appropriate for the
matched study design [17]. The initial multivariable logistic
regression model included those non collinear covariables
found by univariable analysis to be associated with LTFU
(as the dependent variable) with a p-value ≤ 0.25. The final
model was obtained by successively removing variables not
associated at a p-value <0.05 only if the odds ratios for the
remaining variables were unchanged and taking interac-
tions into account. The following known risk factors were
maintained in the final model: low birth weight, prematur-
ity and maternal educational level and socio-professional
activity (as a surrogate for economic status). We performed
a sensitivity analysis where we imputed missing data as a
category for each variable. All statistical analyses were
performed using R 2.15 software.
Results
Baseline characteristics of the study population
In total, 4104 mother-child pairs were enrolled in the first
phase of the Pediacam study between November 2007 and
December 2010, including 2051 HIV-exposed infants and
2053 HIV-unexposed infants. Among the 4104 mother-
infant pairs initially enrolled, 68 were excluded because
data for mother and infant characteristics at enrolment
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were excluded to avoid duplication of maternal character-
istics. Our analyses were thus conducted on the remaining
3913 mother-infant pairs (1964 HIV-exposed and 1949
HIV-unexposed). About 85.4% (3342/3913) of all the
infants enrolled were born in the three maternities partici-
pating in the study, 13.9% (n = 542) in other maternities in
the same cities and 0.7% (n = 29) at home or on their way
to a healthcare facility. The two groups of infants dif-
fered significantly at enrolment (Table 1). The median
maternal age at delivery was 28.6 years [IQR 24.8-
32.5], significantly higher for HIV-infected mothers
than in HIV-uninfected mothers (29.3 years vs 27.7 years,
p < .001). A larger proportion of HIV-infected mothers
than HIV-uninfected mothers delivered outside the Pedia-
cam study sites (25.5% vs 3.6%, p < .001), were multiparous
(84.6% vs 70.1%, p < .001) and had attended more than
four antenatal visits (14.9% vs 9.2%, p < .001). Preterm
birth (13.4% vs 10.6%, p = 0.009) and low birth weight
infants (9.9% vs 5.8%, p < .001) were more frequent for
HIV-infected than HIV-uninfected mothers.
Mother-infants flow after enrolment
Figure 1 illustrates the flow of mother-child pairs from
the enrolment and at each scheduled clinical visit.
Overall, 23.1% (903/3913) of mother-child pairs never
returned for a clinical visit and 0.1% (4/3913) only
returned for visits more than 6 months after enrolment:
these two groups of pairs (n = 907; 23.2%) were consid-
ered as lost to follow-up (LTFU). LTFU was significantly
lower for HIV-infected mother-infant pairs than HIV-
uninfected mother-infant pairs (9.8% vs 36.7%, p < .001).
Among the 188 HIV-infected mother-infant pairs LTFU,
only 67 could be contacted by phone. Among them, 41
infants were alive and 26 (38.8%) deceased. The median
infant age at death was 4 weeks [IQR 1.7-6.1]. Seventy-
six of the 715 HIV-uninfected mother-infant pairs LTFU
could be contacted by phone, and all the infants were
alive.
Factors associated with LTFU
Factors related to LTFU differed between the two mater-
nal HIV status groups. For these analyses, infants who
died before the age of 6 weeks were not excluded (ex-
cluding them does not change the outcome; not shown).
For HIV-infected mothers, univariable analysis indicated
that the following factors were associated with LTFU:
prematurity, low birth weight, infant hospitalization at
birth, young maternal age (<25 years), few antenatal
visits (fewer than 4), delivery by emergency caesarean
section, late HIV diagnosis (during pregnancy or at de-
livery), absence of PMTCT prophylaxis, and TCD4
lymphocyte cell count never determined (Additional files
1, 2, 3 and 4). After adjustment, multivariable analysis(Table 2) found that infants born to mothers aged less
than 25 years (aOR = 2.29, 95% CI [1.18-4.46]) and who
did not take any ART prophylaxis for PMTCT (aOR =
3.45 95% CI [2.30-5.19]), and those delivered by emer-
gency caesarean section (aOR = 2.46, 95% CI [1.47 -4.13])
were more likely to be LTFU.
Among HIV-uninfected mother-infant pairs, being
enrolled at Laquintinie hospital, young maternal age
(<25 years), few antenatal visits (fewer than 4), low ma-
ternal education level, economically disadvantaged fam-
ily, absence of running water at home, absence of a
functional fridge at home, both lower maternal and
paternal education level, and absence of both maternal
and paternal socio-professional activity were associated
in univariable analysis with LTFU (Additional files 1, 2, 3
and 4). Multivariable analysis (Table 3), identified mater-
nal age < 35 years (age <25 years, aOR = 1.96, 95% CI
[1.36-2.81] and 25–35 years, aOR = 1.62, 95% CI [1.15-
2.29]), low maternal level of education (aOR = 2.77, 95%
CI [1.95-3.95]) and mothers being housewives/un-
employed (aOR= 1.56, 95% CI [1.16-2.11]), and remuner-
ated activity of mothers (aOR = 1.52 95% CI [1.15-2.02]) as
remaining independently associated with LTFU. In
addition, the enrolment site, a sampling variable, was inde-
pendently associated with LTFU. Mother-infant pairs
enrolled at Laquintinie Hospital (LH) in Douala more
likely than mother-infant pairs enrolled at the Central
Hospital Maternity (CHM)/Mother and Child Center of
the Chantal Biya Foundation (MCC-CBF) (aOR = 1.29,
(95% CI [1.03-1.61]) to be LTFU. No significant interac-
tions were identified between the characteristics associ-
ated with the variable of interest (LTFU) in univariable
analysis. This analysis did not show differences when
compared to sensitivity analysis including missing data
as a category.Discussion
As in most Sub-Saharan countries, Cameroon experi-
enced a generalized HIV epidemic. The prevalence was
estimated in 2011 to be 4.3% among adults aged 15–49
years with 550,000 people living with HIV and 32,800
deaths in a population of 20 million inhabitants [18].
The use of antiretroviral multitherapy has dramatically
reduced mortality, transforming HIV infection from an
acute to a chronic disease. One consequence is that any
action intended for caring people living with HIV needs
their motivation, making compliance to follow-up a key
for success. We took advantage of the Pediacam cohort,
launched in 2007, constituted of HIV-exposed and HIV-
unexposed infants included in the first week of life and
followed for five years. We used this cohort to evaluate
the proportion of infants who did not return for follow-
up after inclusion in the first phase of the study, and
Table 1 Baseline characteristics of the study population in each group defined by maternal HIV serostatus, ANRS
12140- Pediacam study, Cameroon, 2007-2010
Characteristics (n) Total Maternal HIV serostatus P value
N = 3913 Positive (n = 1964) Negative (n = 1949)
N (%) n (%) n (%)
Mother’s age at delivery (years) (n = 3909) <0.001
<25 1023 (26.2) 385 (19.6) 638 (32.8)
25-35 2417 (61.8) 1320 (67.2) 1097 (56.4)
>35 469 (12.0) 258 (13.1) 211 (10.8)
Marital status (n = 3883) 0.35
single/divorced/widowed 1173 (30.2) 604 (30.9) 569 (29.5)
Married/living with a partner 2710 (69.8) 1351 (69.1) 1359 (70.5)
Maternal level of education (n = 3879) <0.001
None/Primary education 557 (14.4) 371 (19) 186 (9.6)
Secondary education 2395 (61.7) 1251 (64.1) 1144 (59.3)
Higher education 927 (23.9) 329 (16.9) 598 (31)
Maternal professional activity (n = 3849) <0.001
Housewives/unemployed 1433 (37.2) 835 (43) 598 (31.3)
Training/Student 724 (18.8) 242 (12.5) 482 (25.2)
Paid activity 1692 (44) 863 (44.5) 829 (43.4)
Estimated monthly income (FCFA) (n = 3734) <0.001
<50000 1083 (29.0) 751 (39.7) 332 (18.0)
50000-100000 720 (19.3) 339 (17.9) 381 (20.7)
>100000 1022 (27.4) 429 (22.7) 593 (32.2)
Did not answer 909 (24.3) 374 (19.8) 535 (29.1)
Electricity at home (n = 3892) <0.001
No 50 (1.3) 43 (2.2) 7 (0.4)
Yes 3792 (98.7) 1893 (97.8) 1899 (99.6)
Access to tap water at home (n = 3836) <0.001
No 1483 (38.7) 881 (45.5) 602 (31.7)
Yes 2353 (61.3) 1054 (54.5) 1299 (68.3)
Presence of a functional fridge at home (n = 3823) <0.001
No 1450 (37.9) 915 (47.4) 535 (28.3)
Yes 2373 (62.1) 1015 (52.6) 1358 (71.7)
Parity (n = 3890) <0.001
Primiparous 879 (22.6) 302 (15.4) 577 (29.9)
Multiparous 3011 (77.4) 1656 (84.6) 1355 (70.1)
Number of antenatal visits (n = 3779) <0.001
<4 3324 (88.0) 1621 (85.1) 1703 (90.8)
≥4 455 (12.0) 283 (14.9) 172 (9.2)
Place of delivery (n = 3913) <0.001
Home/Other health structure 571 (14.6) 500 (25.5) 71 (3.6)
Pediacam study site 3342 (85.4) 1464 (74.5) 1878 (96.4)
Mode of delivery (n = 3908) 0.07
Vaginal 3482 (89.1) 1768 (90.1) 1714 (88.1)
Elective caesarian section 140 (3.6) 68 (3.5) 72 (3.7)
Emergency caesarian section 286 (7.3) 126 (6.4) 160 (8.2)
Adjusted on infant’s gender and recruitment site.
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Figure 1 Flow diagram of mother-child pairs from the enrolment through each follow-up visit for the ANRS 12140- Pediacam survey.
Cameroon. 2007–2010. *1st, 2nd, and 3rd visits were planned at 6, 10, 14 weeks respectively after delivery.
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(LTFU).
The overall LTFU rate was 23.2% [CI95% 22.2-24.8],
and was significantly lower for HIV-infected mother-
infant pairs (9.8%) than HIV-uninfected mother-infant
pairs (36.7%). Few relevant studies that have addressed
the problem of LTFU included a control group. In a
nested case control study including 594 HIV-uninfected
and 456 HIV-infected mothers in Zimbabwe [19], drop-
out at 9 months was 19%; the higher LTFU rate in HIV-
uninfected mother-infant pairs (23.1%) is similar to our
observation that LTFU among infants born to HIV-
infected mothers was about 3 times higher than among
infants born to HIV-uninfected mothers. The failure of
HIV-uninfected mother-child pairs to return for visits
might reflect their concern about stigmatization. In-
deed, involving HIV-uninfected mothers in a study con-
cerning HIV-infected mothers is a real challenge
because of the possible misinterpretation that involve-
ment indicates HIV positivity [20]. Despite the exist-
ence of information, education and communication
(IEC) activities, stigma within the community is still an
important reality [21]. Also, for many HIV-infected
mothers, the participation in such studies is reinforced
by their desire to help their infant or to facilitate their
access to ART. This factor is not relevant to HIV-
uninfected mothers [22]. Therefore, motivation and dir-
ect benefits associated with participation in this type of
study are not equal for different groups of infants. The
failure of HIV-infected mother-child pairs to return for
scheduled clinical visits (9.6%) in this study was lower
than reported in other African studies, including thoseconducted in PMTCT programmes. In Mozambique,
Ethiopia, Angola, and Cameroon, LTFU rates of 75.17%
[23], 47.96% [24] , 19.27% [9], and 17.55% [25], respect-
ively, have been reported for infants by the age of
3 months. In general, LTFU tends to be lower in cohort
studies than routine PMTCT programs [11]. In a cohort
study conducted in South Africa, 78% of participants
attended their scheduled 12-month visit whereas only
18% returned in the routine PMTCT programme [26].
The high follow-up rate in the Pediacam study may be
due to the reminders by telephone, reimbursement of
transport fees, provision of child care and free vaccines,
and strong coordination.
The factors associated with LTFU differed according
to maternal HIV status. HIV-uninfected mothers
aged ≤ 35 years (<25 years and 25–35 years) more
likely than those >35 years old to be LTFU. Similarly,
Kaplan et al. [27] reported that younger patients were
at greater risk of LTFU with an adjusted odds ratio of
2.2 [95% CI 1.30-3.60]. Recent evidence suggests that
social factors, such as stability (income, education,
occupation), are associated with LTFU [28]. In Africa,
both social and economic stability increases with age.
Most women aged 35 years and above are in marital
relationships (89.9% of women >35 years old live with
a partner versus 72% of women <25 years old). The
probability of being employed is substantially greater
at old than young ages (younger women are more
likely to be in education. The same reasons may ex-
plain why younger mothers are more likely to be
LTFU. Young participants may be geographically more
mobile [29]. Lower maternal education level was also
Table 2 Factors associated with loss-to-follow-up (LTFU,
defined as never attending a clinical visit) for infants
born to HIV-infected mothers, ANRS 12140-Pediacam
study, Cameroon, 2007–2010: Multivariable analysis
Characteristics (N = 1746) Lost to follow up
Adjusted OR [CI95%] P value
Infant
Prematurity
Yes (<37 weeks) 1.36 [0.87-2.15] 0.19
No (≥37 weeks) Ref
Low birth weight
Yes (birth weight < 2500 grs) 1.21 [0.72-2.03] 0.48
No (birth weight≥ 2500 grs) Ref
Mother and socioeconomic status
Maternal age (years) 0.02
<25 2.29 [1.18-4.46]
25-35 1.50 [0.83-2.71]
>35 Ref
Maternal education level 0.26
None/Primary education 1.24 [0.74-2.08]
Secondary education 1.35 [0.93-1.95]
Higher education Ref
Antenatal care and obstetrical
context of delivery
Delivery mode 0.005
Elective caesarian section 1.37 [0.57-3.32]
Emergency caesarian section 2.46 [1.47-4.13]
Vaginal Ref
ART prophylaxis for PMTCT
Never 3.45 [2.3-5.19] <0.001
Yes Ref
Adjusted on infant’s gender, study site, hospitalisation at birth, monthly
income, number of antenatal visits, time of HIV diagnosis, CD4 cell count.
Table 3 Factors associated with loss-to-follow-up (LTFU,
defined as never attending a clinical visit) for infants
born to HIV-uninfected mothers, ANRS 12140- Pediacam
study, Cameroon, 2007–2010: Multivariable analysis
Characteristics (N = 1775) Lost to follow up
Adjusted OR [CI95%] P value
Infant
Recruitment site <0.001
LH 1.29 [1.03-1.61]
EHC 0.54 [0.41-0.69]
MCH/MCC-CBF Ref
Prematurity
Yes (<37 weeks) 1.30 [0.96-1.76] 0.37
No (≥37 weeks) Ref
Low birth weight
Yes (birth weight < 2500 grs) 0.92 [0.61-1.41] 0.46
No (birth weight≥ 2500 grs) Ref
Mother and socioeconomic status
Maternal age (years) <0.001
<25 1.96 [1.36-2.81]
25-35 1.62 [1.15-2.29]
>35 Ref
Maternal education level 0.002
None/Primary education 2.77 [1.95-3.95]
Secondary education 1.60 [1.28-2.00]
Higher education Ref
Maternal socioprofessional activity 0.006
Housewives/Unemployed mothers 1.56 [1.16-2.02]
Remunerated activity 1.52 [1.15-2.02]
Training/Student Ref
Adjusted on infant’s gender, marital status, monthly income, access to tap
water, presence of a functional fridge at home, number of antenatal visits.
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infants born to HIV-uninfected mothers. This obser-
vation contrasts with others studies which report a
higher risk of LTFU among HIV-exposed infants born
to less educated mothers [30]. In India, women with
graduate level education were less likely than women
with less than graduate level education to be LTFU
[31]. The direct benefits of HIV-study participation
are not shared by HIV-uninfected mothers, their mo-
tivation to participate may be associated to their abil-
ity to understand the potential benefits of the study,
such as new scientific information about HIV and its
treatment; this may have a larger effect on educated
participants. More than 90% of the HIV-uninfected
women enrolled in this study had at least a secondary
school level education.Ioannidis et al. reported an association in Malawi
between LTFU and teaching/student occupations: infants
born to HIV-infected mothers who were teachers or
students were less likely to attend follow-up visits. This
might have been due to concerns about stigmatization
from being identified as HIV positive. Our analysis indi-
cated that HIV-unexposed infants born to employed
mothers were more likely to be LTFU possibly because
they do not have enough time off from work to attend
visits. In US, Krishnan et al. reported that activities such
as work or school prevent participants from adhering to
follow-up [29].
LTFU of HIV-infected mother-infant pairs was also
significantly and independently associated with the ab-
sence of ART prophylaxis. This observation is consistent
with findings in Uganda presented by Ahoua et al. [32];
they reported a higher risk of LTFU for patients with
Sidze et al. BMC Public Health  (2015) 15:228 Page 8 of 10incomplete or no ARV prophylaxis. A study in the USA
reported a slightly lower LTFU rate in ARV-experienced
than ARV-naïve mothers, probably due to familiarity
with health-care system and a better understanding of
the importance of follow-up.
We found an association between LTFU and emergency
caesarean section, and this contrasts with a study in
Malawi where this factor was not reported to be associated
with LTFU [30]. However, our finding is similar to obser-
vations in the Pediacam study concerning factors associ-
ated to incomplete infant HIV diagnosis process. It may
be because many of these women are referred from pri-
mary antenatal care settings to the hospitals participating
in the Pediacam survey because of complications of
labour/delivery; these women may prefer to return to their
local health centres for infant follow-up after delivery [14].
A study in Malawi identified low birth weight as a sig-
nificant factor influencing return to follow-up visits [30].
This was attributed to high mortality rate among low
birth weight infants. In our analysis, low birth weight
tended to be associated with LTFU, and was not signifi-
cant in multivariable analysis. Other factors, notably
hospitalization at birth and pre-term, presented the same
characteristics.
In this study, 67 HIV-infected mother-infant pairs who
were LTFU were traced: 26 of the infants were deceased
(Figure 1).
Previous studies identified poor socio-economic condi-
tions as a reason for LTFU. For example, HIV-infected
women in India staying in families with higher economic
status were found to be less likely than women living at
a lower economic status to be LTFU both before and
after delivery [31]. A study in South Africa identified
financial difficulty as the major obstacle to attending
follow-up visits for patients on antiretroviral therapy
[33]. In rural Malawi, inability to afford transport costs
related to the long distances to hospitals has been cited
as impeding the ability to comply with protocol [21]. We
did not find any such factors in our study. This divergence
of results may be a consequence of the different ways that
socio economic factors were assessed in these studies. In
our study, we used monthly income, access to electricity
at home, presence of a functional fridge at home, access to
tap water at home and socio-professional activity as surro-
gates of economic status. We assumed that reimburse-
ment of transport fees, and free milk, vaccines and
biological exam provided by the study minimized the ef-
fects of economic status; also Pediacam operates in urban
areas, where there are fewer socioeconomically disadvan-
taged people than in rural areas.
The factors associated with LTFU in the HIV-infected
mothers group pertained to antenatal care and the obstet-
rical context of delivery; those associated with LTFU in
the HIV-uninfected mothers group were largely relevantto socioeconomic status. For both groups of maternal HIV
status, young maternal age was associated with LTFU.
One of the strengths of this study is its multicentre de-
sign including three referral hospitals with different work-
ing practices and recruitments, reflecting the diversity of
practical management of PMTCT programmes. Moreover,
these centres are located in two large cities of Cameroon
with heterogeneous populations, albeit mostly living in
urban areas. In contrast, recruitment of HIV-infected and
HIV-uninfected women in the same health centres may
have affected the acceptability to, and follow-up of, HIV-
uninfected women, ad this is a limitation of the study. In
addition, the low rate of LTFU among HIV-infected
mother-child pairs, relative to other sub-Saharan Africa
studies, could have reduced the power of the study to
identify factors associated with LTFU.
Conclusions
Factors associated with LTFU (never returning for a
scheduled clinical visit) of mother-child pairs differ ac-
cording to maternal HIV serostatus. For HIV-infected
mother-child pairs, these factors pertain to the quality of
antenatal care and the obstetrical context of delivery
whereas for HIV-uninfected mother-child pairs, they are
related to maternal characteristics and socio-economic
status. Ensuring the quality of antenatal and intrapartum
services could help in improving follow-up. Provision of
training for clinicians in antenatal and intrapartum ser-
vices may help them identify mothers at high risk of
missing follow-up visits. Identification of such cases
would allow targeted counselling and education about
the importance of follow-up.
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